2000
DOI: 10.1016/s0735-1097(00)00725-7
|View full text |Cite
|
Sign up to set email alerts
|

Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices

Abstract: These data suggest that the fourth generation buttoned device is as effective as earlier generation devices, but without significant unbuttoning. Follow-up results remained good, with a reintervention-free rate of 89% at five years.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
34
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 79 publications
(35 citation statements)
references
References 31 publications
1
34
0
Order By: Relevance
“…Cardiac perforation has not (yet) been reported with the HELEX Septal Occluder, but, erosions or perforations leading to pericardial effusions, tamponade, fistulas, and even death have been noted with other atrial septal occlusion devices [10–14]. The exact mechanisms and best ways to avoid perforations with these other devices remains controversial.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiac perforation has not (yet) been reported with the HELEX Septal Occluder, but, erosions or perforations leading to pericardial effusions, tamponade, fistulas, and even death have been noted with other atrial septal occlusion devices [10–14]. The exact mechanisms and best ways to avoid perforations with these other devices remains controversial.…”
Section: Discussionmentioning
confidence: 99%
“…The results of a worldwide multicenter trial with 4th generation buttoned devices were published in 2000 by Rao and colleagues. 11 During a 4-year period ending in September 1997, 475 patients were recruited in the 40 participating centers and brought to the catheterization laboratory with the intention to occlude the ASD.…”
Section: Resultsmentioning
confidence: 99%
“…ASDs have also been associated with a variety of genetic diseases including Down syndrome, DiGeorge syndrome, Ellis‐Van Creveld syndrome, and Holt‐Oram syndrome 47–49 . Since the first transvenous ASD closure was performed by King and Mills in 1974, 50 a number of transcatheter closure devices have been designed, tested, and studied in clinical trials 51–54 . Nearly three decades later, continued technological advancements in device design and delivery methods have allowed transcatheter closure of ASDs to become a routine interventional procedure.…”
Section: Introductionmentioning
confidence: 99%